Αποτελέσματα Αναζήτησης
Objectives. This study seeks to prospectively evaluate the combination of drug “triple therapy dexamethasone 4 mg. ” BID, metoclopramide 10 mg Q6 and octreotide 300 mcg TID to assess tolerability, safety, and effect on symptoms and deobstruction. Methods.
This guideline is developed to assist admitting and treating clinicians in the safe and effective management of patients with potential malignant bowel obstruction. It will have most relevance to doctors in ED, SDMA, SDSA, AMU and other admitting areas. 2.
1 Αυγ 2023 · In practice, there are multiple non-surgical strategies available for patients with malignant bowel obstruction. Treatment should be individualised and palliative care specialists should be sought.
treating patients with malignant bowel obstruction should work to establish consensus guidelines, where feasible, to support medical providers in ensuring compassionate care during this often terminal event for this unique patient group. Malignant bowel obstruction (MBO) is a complex issue affecting numerous cancer patients, most notably those
This guideline provides evidence-based recommendations on the management of malignant bowel obstruction (MBO) for patients with advanced cancer.
The optimal treatment approach is often unclear. We aimed to compare surgical versus non-surgical management with the aim to determine the optimal approach for managing malignant bowel obstruction.
25 Μαρ 2019 · Malignant bowel obstruction (MBO) is a common problem for patients with advanced malignancy, especially colorectal and ovarian cancers. Symptoms include pain, bloating, nausea and vomiting, and inability to eat. Treatment options consist of a wide range of surgical and nonsurgical interventions (medications, endoscopic, or interventional ...
